Prescription Required
Gemibine 1000mg Injection 1ml functions by adapting within cancerous cells, leading to the disruption of DNA construction, and as a result, the death of cancer cells.
This medication falls into the category of chemotherapy drugs, specifically designed for halting the growth of malignant cells.
It operates by changing within malignant cells, generating potent compounds which obstruct the creation of DNA. This obstruction ends up terminating the DNA sequences, causing the disintegration of the DNA, and leading to the death of malignant cells. Moreover, it has a unique capability to augment its own efficiency by decreasing certain DNA building blocks, thereby extending its effect within cancerous cells.
Healthcare experts should administer this medicine. Patients are advised against self-administration. Adhere to the instructions given by doctors or nurses for correct use.
Possible side effects of Gemcitabine could comprise of revulsion, nausea, breathlessness, lower count of red blood cells, blood in urine, headaches, fever, and mutated bowel movements.
There may be a chance of myelosuppression, which would cause reduced blood cell counts. Frequent blood examination is required to keep track of blood cell counts, and dose alterations may be necessitated based on these counter analyses.
If a dosage is forgotten, consume it as soon as remembered. Nonetheless, avoid the forgotten dose if it's time for the next one, and carry on with the standard schedule. Refrain from increasing dosages. Consultation with a doctor for efficient management of miss doses is advised.
The combination of alcohol and medication is viewed as harmful because it can cause excessive sleepiness and increased risks.
Actual evidence of potential harm to the unborn baby makes this medication unsafe during pregnancy. Please refer to your healthcare professional for alternatives in urgent cases.
The usage of this medicine while breastfeeding is not safe as there's data pointing to possible harm to the baby.
There isn't enough information about the effects of this medicine in patients with kidney disease. It is suggested to consult with your doctor and undergo kidney function tests before and during the therapy.
There is inadequate evidence concerning the effects of this medication in liver disease. Personalized advice and monitoring from your doctor are advised.
Cisplatin, a potent pharmaceutical, alters within tumor cells to halt their expansion. It forms active compounds that obstruct with the cell's capacity to create DNA, resulting in the cessation of DNA chains, fracturing them and triggering the tumor cells to perish. Cisplatin also possesses an extraordinary capacity to augment its own potency by decreasing the formation of specific DNA components and extending its residence in the tumor cells. This self-enhancing attribute renders Cisplatin exceptionally efficient in combating cancer compared to other medications.
Non-small cell lung cancer (NSCLC) is the most common type of lung cancer. It occurs when abnormal cells grow and multiply in the lung tissues. NSCLC can be divided into three main types: adenocarcinoma, squamous cell carcinoma, and large cell carcinoma. NSCLC can cause symptoms such as coughing, chest pain, shortness of breath, and weight loss.
Content Updated on
Saturday, 17 Feburary, 2024Prescription Required
Simplify your healthcare journey with Indian Government's ABHA card. Get your card today!
Create ABHA